Jonathan Webster (@leukdocwebster) 's Twitter Profile
Jonathan Webster

@leukdocwebster

Assistant Professor of Oncology, Division of Hematologic Malignancies, Leukemia Group, Johns Hopkins University

ID: 1455559440845848578

calendar_today02-11-2021 15:36:49

16 Tweet

164 Followers

118 Following

Chris Hourigan (@drchrishourigan) 's Twitter Profile Photo

Live action footage of Houriganlab.com arrival at #ASCO2022 Huge AML MRD dataset to present on Tuesday - but also the hoping to use this time away to write the paper...

Keith W Pratz MD (@pratzkw) 's Twitter Profile Photo

We are happy to share Andrew Matthews work on: Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Thx SelinaLuger @ParalkarLab and UPenn leukemia team doi.org/10.1182/blooda…

We are happy to share <a href="/DrAndyMatthews/">Andrew Matthews</a> work on: Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Thx <a href="/SelinaLugerMD/">SelinaLuger</a> @ParalkarLab and UPenn leukemia team doi.org/10.1182/blooda…
Jonathan Webster (@leukdocwebster) 's Twitter Profile Photo

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia nature.com/articles/s4137…

Johns Hopkins Thoracic Oncology (@hopkinsthoracic) 's Twitter Profile Photo

Congratulations to Dr. Kristen A. Marrone, MD on receipt of a multi-year career development award from LUNGevity Foundation to study neoadjuvant immunotherapy and targeted therapy for surgical lung cancer harboring a #kras mutation! lungevity.org/news/media-rel…

Congratulations to Dr. <a href="/kamarroneMD/">Kristen A. Marrone, MD</a> on receipt of a multi-year career development award from <a href="/LUNGevity/">LUNGevity Foundation</a> to study neoadjuvant immunotherapy and targeted therapy for surgical lung cancer harboring a #kras mutation! lungevity.org/news/media-rel…
Rakhi Naik, MD MHS (@redcell_doc) 's Twitter Profile Photo

Embargo lifted! Congratulations to our Johns Hopkins Hematology trainees who were awarded ASH Abstract Achievement Awards!! 🌟Michael Hochman Michael Hochman, Chief Heme Fellow Johns Hopkins Hematology and Oncology Fellowship 🌟Macy Early Macy Early Gatti, ASH Med Student PS Awardee 🌟 Jayla Scott, Hopkins Woodrow Wilson Awardee 🧵

Keith W Pratz MD (@pratzkw) 's Twitter Profile Photo

#ASH2022 Late breaking abstract on frontline Blinatumomab in adult ALL E1910. Amazing results and new SOC. Congratulations Mark Litzow and study team.

#ASH2022 Late breaking abstract on frontline Blinatumomab in adult ALL E1910.  Amazing results and new SOC. Congratulations Mark Litzow and study team.
Jonathan Webster (@leukdocwebster) 's Twitter Profile Photo

Great article from Nicholas Short MD and colleagues with important implications for MRD monitoring in Ph+ ALL and our understanding of the fundamental biology underlying Ph+ ALL vs de novo lymphoid blast crisis of CML vs ?Ph+ ALL with CML-like biology.

Javier Bolaños Meade, MD (@gvhd_meade) 's Twitter Profile Photo

An incredible amount of work with really brilliant people made #BMTCTN1703 a success and the new SOC for #GvHD prophylaxis #PTCyRules #BMTCTN CIBMTR Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM nejm.org/doi/full/10.10…